MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
File(s)s41467-023-40981-9.pdf (3.26 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Aberrant enhancer activation is a key mechanism driving oncogene expression in many cancers. While much is known about the regulation of larger chromosome domains in eukaryotes, the details of enhancer-promoter interactions remain poorly understood. Recent work suggests co-activators like BRD4 and Mediator have little impact on enhancer-promoter interactions. In leukemias controlled by the MLL-AF4 fusion protein, we use the ultra-high resolution technique Micro-Capture-C (MCC) to show that MLL-AF4 binding promotes broad, high-density regions of enhancer-promoter interactions at a subset of key targets. These enhancers are enriched for transcription elongation factors like PAF1C and FACT, and the loss of these factors abolishes enhancer-promoter contact. This work not only provides an additional model for how MLL-AF4 is able to drive high levels of transcription at key genes in leukemia but also suggests a more general model linking enhancer-promoter crosstalk and transcription elongation.
Date Issued
2023-08-25
Date Acceptance
2023-08-18
Citation
Nature Communications, 2023, 14, pp.1-20
ISSN
2041-1723
Publisher
Nature Portfolio
Start Page
1
End Page
20
Journal / Book Title
Nature Communications
Volume
14
Copyright Statement
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/37626123
Subjects
Cell Cycle Proteins
Humans
Leukemia
Myeloid-Lymphoid Leukemia Protein
Nuclear Proteins
Oncogene Proteins, Fusion
Promoter Regions, Genetic
Regulatory Sequences, Nucleic Acid
Transcription Factors
Publication Status
Published
Coverage Spatial
England
Article Number
5208
Date Publish Online
2023-08-25